SAPORITI, GIORGIA NATASCIA
 Distribuzione geografica
Continente #
EU - Europa 2.511
AS - Asia 1.929
NA - Nord America 1.573
SA - Sud America 212
AF - Africa 62
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.308
Nazione #
US - Stati Uniti d'America 1.476
DE - Germania 914
CN - Cina 746
GB - Regno Unito 470
IT - Italia 436
SG - Singapore 391
HK - Hong Kong 130
BR - Brasile 123
IN - India 117
SE - Svezia 116
VN - Vietnam 114
FR - Francia 100
RU - Federazione Russa 100
JP - Giappone 90
BD - Bangladesh 79
TR - Turchia 72
CA - Canada 61
NL - Olanda 61
UA - Ucraina 58
ES - Italia 46
FI - Finlandia 44
KR - Corea 37
IE - Irlanda 36
CO - Colombia 35
AR - Argentina 26
MX - Messico 25
TH - Thailandia 25
CI - Costa d'Avorio 22
PK - Pakistan 22
PL - Polonia 20
BE - Belgio 19
EU - Europa 19
EG - Egitto 18
IL - Israele 18
AU - Australia 16
CH - Svizzera 16
ID - Indonesia 16
SA - Arabia Saudita 16
DK - Danimarca 13
PT - Portogallo 13
AT - Austria 10
GR - Grecia 10
UZ - Uzbekistan 10
IQ - Iraq 7
TW - Taiwan 7
MY - Malesia 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
UY - Uruguay 6
CL - Cile 5
EC - Ecuador 5
MA - Marocco 5
IR - Iran 4
JO - Giordania 4
NO - Norvegia 4
TN - Tunisia 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
IS - Islanda 3
KW - Kuwait 3
PY - Paraguay 3
RE - Reunion 3
RS - Serbia 3
VE - Venezuela 3
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
KE - Kenya 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
BH - Bahrain 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 6.327
Città #
Frankfurt am Main 758
Southend 366
Beijing 267
Singapore 227
Ashburn 191
Chandler 126
Milan 113
Hong Kong 106
Dallas 68
San Jose 67
Wilmington 52
Ann Arbor 49
Seattle 49
Los Angeles 46
New York 44
Ho Chi Minh City 41
Council Bluffs 40
Hefei 40
Dublin 34
Princeton 34
Jacksonville 32
Tokyo 32
Bengaluru 30
Hanoi 30
Helsinki 29
Rome 27
Nanjing 26
Redwood City 26
Santa Clara 26
Shanghai 26
Guangzhou 24
Toronto 24
Hangzhou 23
Abidjan 22
São Paulo 22
Phoenix 21
Redmond 21
Houston 20
Lauterbourg 20
Boardman 18
Buffalo 17
Woodbridge 17
Bangkok 16
Brussels 16
Cambridge 16
Moscow 16
Bogotá 15
Des Moines 15
Montreal 15
Turin 15
Barcelona 14
Delhi 14
Mountain View 14
Dearborn 13
Fairfield 13
Istanbul 13
Jinan 13
Somerville 13
Paris 12
Riyadh 12
Andover 11
Ankara 11
Cangzhou 11
Rio de Janeiro 11
Sakarya 11
Serra 11
Yavne 11
Brasília 10
Buenos Aires 10
Hanover 10
Medellín 10
Chengdu 9
Jakarta 9
Naples 9
Tianjin 9
Atlanta 8
Cairo 8
Chennai 8
Da Nang 8
Hebei 8
Lodz 8
London 8
Melbourne 8
Rochester 8
San Diego 8
Seoul 8
Sydney 8
Bologna 7
Changsha 7
Florence 7
Hyderabad 7
Lahore 7
Orem 7
Piacenza 7
Shenyang 7
Taipei 7
Berlin 6
Chicago 6
Columbus 6
East Providence 6
Totale 3.842
Nome #
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 1.365
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 464
Caratterizzazione molecolare della sindrome di Sezary e possibili risvolti prognostico-terapeutici. 445
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 338
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 336
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 334
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 328
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 252
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 250
Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients 245
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin 237
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 225
In vitro anti-leukaemia activity of sphingosine kinase inhibitor 222
High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes 217
Reduced-intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation Represents a Feasible and Effective Treatment Strategy for Advanced Mycosis Fungoides and Sezary Syndrome 185
New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia 182
Blastic Plasmacytoid Dendritic Cell Neoplasm: clinic-pathologic and molecular data from a single medical center 178
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse 167
Cancer stem cells in hematological disorders : current and possible new therapeutic approaches 167
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience 138
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial 123
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents 84
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study 28
Totale 6.510
Categoria #
all - tutte 13.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022463 49 23 45 31 29 27 49 22 58 31 27 72
2022/2023608 58 58 48 47 75 76 25 30 74 38 29 50
2023/2024939 33 28 32 39 130 52 109 95 59 98 123 141
2024/20251.125 126 143 124 113 69 29 38 86 41 93 84 179
2025/20261.695 192 124 200 144 124 113 195 66 143 134 198 62
Totale 6.510